Literature DB >> 28319464

The Dr. Jekyll and Mr. Hyde complexity of the macrophage response in disease.

Danielle Y F Twum1, Lauren Burkard-Mandel1, Scott I Abrams2.   

Abstract

Macrophages comprise a highly diverse cell population expressing a continuum of biologic activities dictated by exposure to a plethora of inflammatory cues. Moreover, in contrast to most other hematopoietic populations, macrophages can arise from multiple sites-namely, the bone marrow or yolk sac, adding to the complexity of macrophage biology during health and disease. Nonetheless, it is this very type of diversity that is indispensable for macrophages to respond effectively to pathologic insults. Most of the interest in macrophage biology has been devoted to bone marrow-derived populations, but it is now becoming clearer that tissue-resident populations, which arise from distinct hematopoietic compartments, serve critical roles in host defense, including protection against neoplastic disease. Depending on the inflammatory milieu, macrophages can behave as a "two-edged sword," playing either host-protective (i.e., antitumor) or host-destructive (i.e., protumor) roles. Accordingly, we review herein the mechanisms that instruct macrophage functional diversity within their microenvironments, with special emphasis on transcriptional regulation, which is less understood. Given their polarizing positions in disease processes, we will also provide an overview of strategies that target macrophages or their effector mechanisms for therapeutic purposes. © Society for Leukocyte Biology.

Entities:  

Keywords:  cancer; immunotherapy; macrophages; transcriptional regulation

Mesh:

Year:  2017        PMID: 28319464      PMCID: PMC5505749          DOI: 10.1189/jlb.4MR1116-479R

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  81 in total

Review 1.  The chemokine system in diverse forms of macrophage activation and polarization.

Authors:  Alberto Mantovani; Antonio Sica; Silvano Sozzani; Paola Allavena; Annunciata Vecchi; Massimo Locati
Journal:  Trends Immunol       Date:  2004-12       Impact factor: 16.687

Review 2.  The IRF family transcription factors in immunity and oncogenesis.

Authors:  Tomohiko Tamura; Hideyuki Yanai; David Savitsky; Tadatsugu Taniguchi
Journal:  Annu Rev Immunol       Date:  2008       Impact factor: 28.527

Review 3.  Macrophage plasticity and polarization in liver homeostasis and pathology.

Authors:  Antonio Sica; Pietro Invernizzi; Alberto Mantovani
Journal:  Hepatology       Date:  2014-04-01       Impact factor: 17.425

Review 4.  Tissue macrophage identity and self-renewal.

Authors:  Rebecca Gentek; Kaaweh Molawi; Michael H Sieweke
Journal:  Immunol Rev       Date:  2014-11       Impact factor: 12.988

5.  Obesity increases sensitivity to endotoxin liver injury: implications for the pathogenesis of steatohepatitis.

Authors:  S Q Yang; H Z Lin; M D Lane; M Clemens; A M Diehl
Journal:  Proc Natl Acad Sci U S A       Date:  1997-03-18       Impact factor: 11.205

6.  The cellular and molecular origin of tumor-associated macrophages.

Authors:  Ruth A Franklin; Will Liao; Abira Sarkar; Myoungjoo V Kim; Michael R Bivona; Kang Liu; Eric G Pamer; Ming O Li
Journal:  Science       Date:  2014-05-08       Impact factor: 47.728

Review 7.  Macrophage biology in development, homeostasis and disease.

Authors:  Thomas A Wynn; Ajay Chawla; Jeffrey W Pollard
Journal:  Nature       Date:  2013-04-25       Impact factor: 49.962

8.  Microglia initiate central nervous system innate and adaptive immune responses through multiple TLRs.

Authors:  Julie K Olson; Stephen D Miller
Journal:  J Immunol       Date:  2004-09-15       Impact factor: 5.422

9.  Yolk Sac Macrophages, Fetal Liver, and Adult Monocytes Can Colonize an Empty Niche and Develop into Functional Tissue-Resident Macrophages.

Authors:  Lianne van de Laar; Wouter Saelens; Sofie De Prijck; Liesbet Martens; Charlotte L Scott; Gert Van Isterdael; Eik Hoffmann; Rudi Beyaert; Yvan Saeys; Bart N Lambrecht; Martin Guilliams
Journal:  Immunity       Date:  2016-03-15       Impact factor: 31.745

Review 10.  Tumor-associated macrophages: from mechanisms to therapy.

Authors:  Roy Noy; Jeffrey W Pollard
Journal:  Immunity       Date:  2014-07-17       Impact factor: 31.745

View more
  5 in total

1.  Characterization of heart macrophages in rhesus macaques as a model to study cardiovascular disease in humans.

Authors:  Daniel I Petkov; David X Liu; Carolina Allers; Peter J Didier; Elizabeth S Didier; Marcelo J Kuroda
Journal:  J Leukoc Biol       Date:  2019-07-09       Impact factor: 4.962

Review 2.  Myeloid-driven mechanisms as barriers to antitumor CD8+ T cell activity.

Authors:  Sean H Colligan; Stephanie L Tzetzo; Scott I Abrams
Journal:  Mol Immunol       Date:  2019-12-26       Impact factor: 4.407

3.  IFN regulatory factor-8 expression in macrophages governs an antimetastatic program.

Authors:  Danielle Yf Twum; Sean H Colligan; Nicholas C Hoffend; Eriko Katsuta; Eduardo Cortes Gomez; Mary Lynn Hensen; Mukund Seshadri; Michael J Nemeth; Scott I Abrams
Journal:  JCI Insight       Date:  2019-02-07

4.  Mosloflavone-Resveratrol Hybrid TMS-HDMF-5z Exhibits Potent In Vitro and In Vivo Anti-Inflammatory Effects Through NF-κB, AP-1, and JAK/STAT Inactivation.

Authors:  Seo-Yeon Kim; Ahmed H E Hassan; Kyung-Sook Chung; Su-Yeon Kim; Hee-Soo Han; Hwi-Ho Lee; Seang-Hwan Jung; Kwang-Young Lee; Ji-Sun Shin; Eungyeong Jang; Seolmin Yoon; Yong Sup Lee; Kyung-Tae Lee
Journal:  Front Pharmacol       Date:  2022-04-21       Impact factor: 5.988

5.  High CD206 levels in Hodgkin lymphoma-educated macrophages are linked to matrix-remodeling and lymphoma dissemination.

Authors:  Annekatrin Arlt; Frederike von Bonin; Thorsten Rehberg; Paula Perez-Rubio; Julia C Engelmann; Katharina Limm; Sarah Reinke; Christian Dullin; Xueni Sun; Rieke Specht; Markus Maulhardt; Franziska Linke; Gertrude Bunt; Wolfram Klapper; Martina Vockerodt; Jörg Wilting; Tobias Pukrop; Katja Dettmer; Wolfram Gronwald; Peter J Oefner; Rainer Spang; Dieter Kube
Journal:  Mol Oncol       Date:  2020-01-28       Impact factor: 6.603

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.